CLINICAL_TRIALS trial_result · 2024-05-21

Clinical Trial Update: Ghrelin (OXE--103) for Acute Concussion Management [Phase 2]

Phase 2 clinical trial evaluating ghrelin (OXE-103) for acute concussion management has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Michael Rippee | Conditions: Concussion, Brain, Traumatic Brain Injury | Phase 2 | Status: COMPLETED | Results posted: 2024-05-21